Tag: neurogenic-biotech-corp

Pfizer to Make $2.3 Billion Deal to Acquire Trillium, Blood Cancer Drugmaker
On Monday, Pfizer Inc. announced it would buy Canadian drug developer Trillium Therapeutics Inc via a $2.26 billion deal to reinforce its investments in blood cancer therapies. Pfizer already acquired a $25 million stake in...